嬡倍斯靜脈凍晶注射劑 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

嬡倍斯靜脈凍晶注射劑

中化裕民健康事業股份有限公司 台北市中正區襄陽路23號8樓 (70761994) - pemetrexed disodium hemipentahydrate;;pemetrexed disodium hemipentahydrate - 凍晶注射劑 - pemetrexed disodium hemipentahydrate (1004002430) (eq. to pemetrexed.....100mg)mg; pemetrexed disodium hemipentahydrate (1004002430) (eq. to pemetrexed.....500mg)mg - pemetrexed - 1.pemetrexed併用cisplatin是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第一線化療用藥。2.pemetrexed單一藥物是局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.pemetrexed單一藥物是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第二線治療用藥。4.pemetrexed與cisplatin併用於治療惡性肋膜間質細胞瘤。

派得健凍晶注射劑100毫克 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

派得健凍晶注射劑100毫克

台灣瑞迪博士有限公司 臺北市信義區信義路5段7號57樓之1(5727室) (42992299) - pemetrexed disodium heptahydrate - 凍晶注射劑 - pemetrexed disodium heptahydrate (1004002410) pemetrexed disodium (eq. to pemetrexed.....100mg)mg - pemetrexed - 1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第一線化療用藥。2.pemetrexed單一藥物是局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第二線治療用藥。4.與cisplatin併用於治療惡性助膜間質細胞瘤。

派得健凍晶注射劑500毫克 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

派得健凍晶注射劑500毫克

台灣瑞迪博士有限公司 臺北市信義區信義路5段7號57樓之1(5727室) (42992299) - pemetrexed disodium heptahydrate - 凍晶注射劑 - pemetrexed disodium heptahydrate (1004002410) pemetrexed disodium (eq. to pemetrexed.....500mg)mg - pemetrexed - 1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第一線化療用藥。2.pemetrexed單一藥物是局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第二線治療用藥。4.與cisplatin併用於治療惡性助膜間質細胞瘤。

欣保康優靜脈營養輸注液 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

欣保康優靜脈營養輸注液

臺灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - glucose anhydrous;;calcium chloride dihydrate;;l-isoleucine;;l-leucine;;lysine l- (hcl);;l-methionine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;arginine l- (monoglutamate);;histidine l- (hcl monohydrate);;l-alanine;;l-aspartic acid;;glutamic acid l-;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-proline;;l-serine;;magnesium acetate tetrahydrate;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;potassium dihydrogen phosphate;;potassium hydroxide;;sodium hydroxide - 注射劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) 1.63mg; calcium chloride dihydrate (4012000350) 0.6mg; magnesium acetate tetrahydrate (4012001450) 1.08mg; glucose anhydrous (4020000750) 240mg; l-alanine (4020100202) 8.49mg; l-aspartic acid (4020100402) 2.63mg; glutamic acid l- (4020100702) 6.14mg; l-isoleucine (4020101002) 4.11mg; l-leucine (4020101202) 5.48mg; l-methionine (4020101502) 3.42mg; l-phenylalanine (4020101702) 6.15mg; l-proline (4020101802) 5.95mg; l-serine (4020101902) 5.25mg; l-threonine (4020102002) 3.18mg; l-tryptophan (4020102102) 1mg; l-valine (4020102302) 4.54mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 2.89mg; arginine l- (monoglutamate) (4020109342) 4.73mg; histidine l- (hcl monohydrate) (4020109922) 2.19mg; lysine l- (hcl) (4020191312) 3.98mg; potassium dihydrogen phosphate (5612001920) 2.00mg; potassium hydroxide (9600024100) 0.62mg; sodium hydroxide (9600028200) 1.14mg - combinations - 無法經口服攝食或腸道吸收營養、功能不全有禁忌症時,對中等到嚴重異化作用狀態的病人的靜脈營養提供氨基酸、 葡萄糖、電解質和液體。欣保康優靜脈營養輸注液適用於成人和 2 到17 歲的兒童。

欣保康力靜脈營養輸注液 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

欣保康力靜脈營養輸注液

臺灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - methionine;;phenylalanine;;threonine;;tryptophan;;arginine monoglutamate l-;;histidine hcl monohydrate;;alanine;;aspartic acid;;glutamic acid;;proline;;serine;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;potassium hydroxide;;sodium hydroxide;;glucose (monohydrate);;sodium chloride;;calcium chloride dihydrate;;leucine;;lysine hcl;;glycine (eq to aminoacetic acid)(eq to glycocoll);;magnesium acetate tetrahydrate;;valine;;isoleucine;;potassium dihydrogen phosphate - 注射劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) 1.56gm; calcium chloride dihydrate (4012000350) 0.37gm; magnesium acetate tetrahydrate (4012001450) 0.86gm; sodium chloride (4012002100) 0.17gm; glucose (monohydrate) (4020009760) 88.00gm; alanine (4020100200) 4.85gm; arginine monoglutamate l- (4020100342) 4.98gm; aspartic acid (4020100400) 1.50gm; glutamic acid (4020100700) 1.22gm; histidine hcl monohydrate (4020100915) 1.69gm; isoleucine (4020101000) 2.34gm; leucine (4020101200) 3.13gm; lysine hcl (4020101310) 2.84gm; methionine (4020101500) 1.96gm; phenylalanine (4020101700) 3.51gm; proline (4020101800) 3.40gm; serine (4020101900) 3.00gm; threonine (4020102000) 1.82gm; tryptophan (4020102100) 0.57gm; valine (4020102300) 2.60gm; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 1.65gm; potassium dihydrogen phosphate (5612001920) 0.78gm; potassium hydroxide (9600024100) gm; sodium hydroxide (9600028200) 0.50gm - combinations - 無法經口服攝食或腸道吸收營養、功能不全或有禁忌症時,對輕微到中等異化作用狀態的病人的靜脈營養提供氨基酸、葡萄糖、電解質和液體。欣保康力靜脈營養輸注液適用於成人和2 到17 歲的兒童。

“百特”歐諾美 N4-550E 輸注乳液 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

“百特”歐諾美 n4-550e 輸注乳液

百特醫療產品股份有限公司 臺北市大安區敦化南路2段95號28樓 (12350071) - l-alanine;;l-arginine;;l-glycine;;l-histidine;;l-isoleucine;;l-leucine;;lysine l-;;l-methionine;;l-phenylalanine;;l-proline;;l-serine;;l-threonine;;l-tryptophan;;l-tyrosine;;l-valine;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;sodium glycerophosphate 5h2o;;potassium chloride;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;glucose;;calcium chloride dihydrate;;refine soya + olive oil - 注射劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) mg; potassium chloride (4012001800) mg; l-alanine (4020100202) mg; l-arginine (4020100302) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; lysine l- (4020101302) (as lysine.hcl 3.98g)mg; l-methionine (4020101502) mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; l-glycine (4020102401) mg; sodium glycerophosphate 5h2o (9200008550) mg; calcium chloride dihydrate (4012000350) mg; glucose (4020000700) (as glucose monohydrate 220.0 mg)mg; refine soya + olive oil (9200027040) mg - combinations - 適於成人及二歲以上孩童在無法或因有禁忌症而不適宜進食或使用口服腸道營養劑時之靜脈營養。

"百特" 歐諾美N7-1000E輸注乳液 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

"百特" 歐諾美n7-1000e輸注乳液

百特醫療產品股份有限公司 臺北市大安區敦化南路2段95號28樓 (12350071) - l-alanine;;l-arginine;;l-glycine;;l-histidine;;l-isoleucine;;l-leucine;;lysine l-;;l-methionine;;l-phenylalanine;;l-proline;;l-serine;;l-threonine;;l-tryptophan;;l-tyrosine;;l-valine;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;sodium glycerophosphate 5h2o;;potassium chloride;;magnesium chloride hexahydrate (eq to magnesium chloride 6h2o);;glucose;;calcium chloride;;refine soya + olive oil - 注射劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; magnesium chloride hexahydrate (eq to magnesium chloride 6h2o) (4012001550) mg; potassium chloride (4012001800) mg; l-alanine (4020100202) mg; l-arginine (4020100302) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; lysine l- (4020101302) mg; l-methionine (4020101502) mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; l-glycine (4020102401) mg; sodium glycerophosphate 5h2o (9200008550) mg; calcium chloride (4012000300) mg; glucose (4020000700) mg; refine soya + olive oil (9200027040) mg - combinations - 適用於成人及二歲以上孩童在無法或因有禁忌症而不適宜進食或使用口服腸道營養劑時之靜脈營養。

欣保富力靜脈營養輸注液 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

欣保富力靜脈營養輸注液

台灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - isoleucine;;leucine;;lysine hcl;;methionine;;threonine;;valine;;arginine;;histidine hcl monohydrate;;alanine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;aspartic acid;;glutamic acid;;proline;;serine;;phenylalanine;;tryptophan;;glucose monohydrate;;sodium hydroxide;;sodium chloride;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;sodium dihydrogen phosphate dihydrate;;potassium acetate;;magnesium acetate tetrahydrate;;calcium chloride dihydrate;;zinc acetate dihydrate;;triglycerides medium chain;;soybean oil ( eq to soya bean oil) - 注射劑 - potassium acetate (4008000100) mg; sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; calcium chloride dihydrate (4012000350) mg; magnesium acetate tetrahydrate (4012001450) mg; sodium chloride (4012002100) mg; glucose monohydrate (4020000760) (eq. to anhydrous glucose 64.0mg)mg; soybean oil ( eq to soya bean oil) (4020001600) mg; alanine (4020100200) mg; arginine (4020100300) mg; aspartic acid (4020100400) mg; glutamic acid (4020100700) mg; histidine hcl monohydrate (4020100915) (eq. to histidine 1.0 mg)mg; isoleucine (4020101000) mg; leucine (4020101200) mg; lysine hcl (4020101310) (eq. to lysine 1.81mg)mg; methionine (4020101500) mg; phenylalanine (4020101700) mg; proline (4020101800) mg; serine (4020101900) mg; threonine (4020102000) mg; tryptophan (4020102100) mg; valine (4020102300) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; sodium dihydrogen phosphate dihydrate (5612002611) mg; triglycerides medium chain (5640001102) mg; zinc acetate dihydrate (9200010550) ug; sodium hydroxide (9600028200) mg - combinations - 患者在無法使用或不適宜或不充足使用口服,腸道營養劑時,作為靜脈營養治療之熱量、必需脂肪酸、胺基酸、電解質及液體的補充。

派癌休注射劑 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

派癌休注射劑

台灣東洋藥品工業股份有限公司 台北市南港區園區街3之1號3樓 (11821341) - pemetrexed disodium 2.5 hydrate - 注射劑 - pemetrexed disodium 2.5 hydrate (1004002420) equal to pemetrexed 25mgmg - pemetrexed - 1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第一線化療用藥。2.單一藥物是局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第二線治療用藥。4.與pembrolizumab及含鉑化學療法併用,做為轉移性,不具有egfr或alk腫瘤基因異常之非鱗狀非小細胞肺癌的第一線治療藥物。5.與cisplatin併用於治療惡性肋膜間質細胞瘤。

易得平錠 80 毫克 台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

易得平錠 80 毫克

台灣賽特瑞恩有限公司 臺北市信義區松仁路97號3樓之1 (52422868) - tak-491 (azilsartan medoxomil (as potassium salt)) - 錠劑 - tak-491 (azilsartan medoxomil (as potassium salt)) (2408007110) as the free acid 80mgmg - azilsartan medoxomil - 治療高血壓